论文部分内容阅读
Background-Whether the risks of stroke, systemic embolism, and major bleeding vary between paroxysmal and sustained atrial fibrillation (AF) remains controversial, and evidence is lacking regarding the superiority of anticoagulation for paroxysmal AF patients.